New Issues
Dr Martens valued at £3.7bn after strong demand for IPO
Dr Martens will be valued at £3. 7bn when the shoe company floats after high demand from investors for its shares.
Kuaishou's Hong Kong IPO could value company at $60bn
Kuaishou’s initial public offering on the Hong Kong stock exchange could see the Chinese online short video company valued at $60bn.
Dr Martens confirms IPO for Feb; Seeks FTSE listing
Iconic UK bootmaker Dr Martens could be listed on the Stock Exchange in London by the start of next month, the business said on Monday, adding that it hoped to be included in an FTSE index.
Sunday newspaper round-up: New Covid strains, Lockdown measures, Google
Britain will be able to vaccinate the entire nation against dangerous new Covid strains within four months after a £158m super-factory opens later this year, The Telegraph can disclose. Dr Matthew Duchars, chief executive of the Vaccines Manufacturing Innovation Centre (VMIC), revealed the Oxfordshire facility will be capable of producing 70m doses of an emergency vaccine manufactured entirely on British soil. - Sunday Telegraph.
Moonpig becomes latest company to pursue London IPO
Online card retailer Moonpig has unveiled plans for a potential £1bn London listing following a surge in revenues.
Iconic bootmaker Dr Martens plans IPO
Classic British boot brand Dr Martens has unveiled plans to float on the London Stock Exchange.